Paul Tudor Jones Merck & Co., Inc. Call Options Transaction History

Tudor Investment Corp Et Al

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $1.93 Million - $2.24 Million	-17,400 Reduced 57.43%	12,900 $1.46 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $4.59 Million - $4.93 Million	-37,100 Reduced 55.04%	30,300 $3.75 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $67,944 - $79,170	600 Added 0.9%	67,400 $8.89 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $5.41 Million - $5.89 Million	54,000 Added 421.88%	66,800 $7.28 Million
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $257,375 - $285,825	-2,500 Reduced 16.34%	12,800 $1.32 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $3.76 Million - $4.1 Million	-34,600 Reduced 69.34%	15,300 $1.77 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $5.14 Million - $5.73 Million	49,900 New	49,900 $5.31 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $321,214 - $360,848	-3,800 Reduced 61.29%	2,400 $207,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $192,027 - $217,672	2,300 Added 58.97%	6,200 $564,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $279,552 - $307,437	3,900 New	3,900 $293,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.